Oncología Hepática
Trinity College Dublin
Dublín, IrlandaPublications en collaboration avec des chercheurs de Trinity College Dublin (3)
2024
-
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
Annals of Oncology, Vol. 35, Núm. 5, pp. 448-457
-
Himalaya Overall Survival Prominence and Other Routes to the Peak
JAMA Oncology